Literature DB >> 15838429

Radiolabelling of poly(histidine) derivatized biodegradable microspheres with the 188Re tricarbonyl complex [188Re(CO)3(H2O)3]+.

Junfeng Yu1, Urs O Häfeli, Jiaoyun Xia, Shiqiang Li, Mo Dong, Duanzhi Yin, Yongxian Wang.   

Abstract

OBJECTIVES: Many radiopharmaceuticals have been studied as radiation synovectomy agents. In this study, we developed a new potential agent for radiation synovectomy: poly(lactic acid)-histidine (PLA-his) microspheres radiolabelled with [188Re(CO)3(H2O)3]+.
METHODS: The reaction conditions for the chelation of [188Re(CO)3(H2O)3]+ and the radiolabelling of PLA microspheres were optimized and the stabilities for both steps tested in vitro.
RESULTS: The chelation efficiency of [188Re(CO)3(H2O)3]+ reached 93.12 +/- 1.82% with >95% radiochemical purity once the colloidal and free 188Re were removed by a small Sep-Pak column (Plus QMA). More than 90% of radioactivity stayed in the [188Re(CO)3(H2O)3]+ form over 5 h. The radiolabelling efficiency of PLA-his microspheres with [188Re(CO)3(H2O)3]+ was above 92%. After 3 days incubation at 37 degrees C in calf serum, more than 80% of the radioactivity was still bound to the microspheres.
CONCLUSION: Such microspheres are potentially useful as a radiation synovectomy agent for the treatment of chronically inflamed arthritic joints. Furthermore, they might be valuable in cancer brachytherapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15838429     DOI: 10.1097/00006231-200505000-00010

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  4 in total

Review 1.  Labeling biomolecules with radiorhenium: a review of the bifunctional chelators.

Authors:  Guozheng Liu; Donald J Hnatowich
Journal:  Anticancer Agents Med Chem       Date:  2007-05       Impact factor: 2.505

2.  Evaluation of biodistribution and antitumor effects of (188)Re-rhk5 in a mouse model of lung cancer.

Authors:  Rui Guo; Sheng Liang; Yufei Ma; Hua Shen; Haoping Xu; Biao Li
Journal:  Oncol Lett       Date:  2011-06-16       Impact factor: 2.967

3.  Synthesis of the first radiolabeled 188Re N-heterocyclic carbene complex and initial studies on its potential use in radiopharmaceutical applications.

Authors:  Thomas Wagner; Brian M Zeglis; Sam Groveman; Claudia Hille; Alexander Pöthig; Lynn C Francesconi; Wolfgang A Herrmann; Fritz E Kühn; Thomas Reiner
Journal:  J Labelled Comp Radiopharm       Date:  2014-05-29       Impact factor: 1.921

Review 4.  Transarterial Radioembolization (TARE) Agents beyond 90Y-Microspheres.

Authors:  C Bouvry; X Palard; J Edeline; V Ardisson; P Loyer; E Garin; N Lepareur
Journal:  Biomed Res Int       Date:  2018-12-31       Impact factor: 3.246

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.